Skip to main content
SpringerLink
Log in

Re.: Oral administration of a certain strain of liveEscherichia coli for intestinal disorders? (Infection 23 [1995] 51–54)

  • Correspondence
  • Published:
Infection Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Expert's Opinion Poll Oral administration of a certain strain of liveEscherichia coli for intestinal disorders? Infection 23 (1995) 51–54.

    Google Scholar 

  2. Seeliger, H. Colibakterien in heutiger Sicht. Lab. med. 15 (1991) 130–131.

    Google Scholar 

  3. Ardeypharm GmbH: Collection of research reports on pharmacology, toxicology, and microbiology ofE. coli strain Nissle 1917 (Mutaflor®), deposited registration files.

  4. Lodinova, R., Jouja, V., Lanc, A. Influence of the intestinal flora on the development of immune reactions in infants. J. Bacteriol. 93 (1967) 797–800.

    Google Scholar 

  5. Lodinova, R., Jouja, V., Lanc, A. Experimentelle Besiedlung des Darmtrakts von Neugeborenen mit demE. coli O83 und Untersuchungen über die Bildung von Antikörpern. Z. Immunitätsforsch. Allergie Klin. Immunol. 133 (1967) 229–237.

    Google Scholar 

  6. Lodinova-Zadnikova, R., Slavikova, M., Tlaskalova-Hogenova, H., Adlerberth, I., Hanson, L. A., Wold, A., Carlsson, B., Svanborg, C., Mellander, L. The antibody response in breast-fed and non-breast-fed infants after artificial colonization of the intestine withE. coli O83. Pediat. Res. 29 (1991) 396–399.

    Google Scholar 

  7. Lodinova-Zadnikova, R., Tlaskalova, H., Bartakova, Z. The antibody response in infants after colonization of the intestine withE. coli O83. Artificial colonization used as a prevention against nosocomial infections. In:Mestecky, J., Blair, C., Ogra, P. L. (eds.): Immunology of milk and the neonate. Advances in experimental medicine and biology, vol. 310. Plenum Press, New York 1991, pp. 329–335.

    Google Scholar 

  8. Sonnenborn, U., Eiteljörge, K., Lodinova-Zadnikova, R. (manuscript in preparation).

  9. Rietschel, E. T., Brade, H. Bakterielle Endotoxine. Spektrum der Wissenschaft 1 (1993) 34–42.

    Google Scholar 

  10. Schulze, J., Lorenz, A., Mandel, L. Colonization ofEscherichia coli in different gnotobiotic animal models. Microb. Ecol. Health Dis. 5 (1992) IV-V.

    Google Scholar 

  11. Mandel, L., Trebichavsky, I., Splichal, L., Schulze, J.: Stimulation of intestinal immune cells byE. coli in gnotobiotic piglets. Abstr. (poster presentation), 7th International Congress of Mucosal Immunology, Prague, 16th–20th August 1992.

  12. Hockertz, S. Immunmodulierende Wirkung von abgetöteten apathogenenEscherichia coli, Stamm Nissle 1917, auf das Makrophagensystem. Arzneimittelforschung 41 (II) (1991) 1108–1112.

    Google Scholar 

  13. Hockertz, S., Lohmann-Matthes, M. L.: Role of macrophages in prevention of infections and their stimulation by microbial products. Microb. Ecol. Health Dis. 5, IV (1992).

  14. Schroten, H.: Model systems for bacterial colonisation of the surface of mucosal membranes: Adhesion of differentEscherichia coli strains to human buccal epithelial cells from persons of different age groups. Microb. Ecol. Health Dis. 5, V (1992).

  15. Schröder, H. Entwicklung der aeroben Darmflora bei Neugeborenen nach Kolonisierung mit demE. coli-Stamm Nissle 1917. Der Kinderarzt 23 (1992) 1619–1625.

    Google Scholar 

  16. Lodinova-Zadnikova, R., Tlaskalova-Hogenova, H., Sonnenborn, U. Local and serum antibody response in full-term and premature infants after artificial colonization of the intestine withE. coli strain Nissle 1917 (Mutalfor®). Pediatr. Allergy Immunol. 3 (1992) 43–48.

    Google Scholar 

  17. Sonnenborn, U., Greinwald, R. Beziehungen zwischen Wirtsorganismus und Darmflora, 2. Aufl. Schattauer, Stuttgart, New York 1991.

    Google Scholar 

  18. 1. Interdisziplinäres Symposium — Darmflora in Symbiose und Pathogenität, Essen 27 Feb. 1991: Der Internist (Suppl.) (1991).

  19. 2. Interdisziplinäres Symposium — Darmflora in Symbiose und Pathogenität, Attendorn 5.–7. März 1992: Der Internist (Suppl.) (1992). Abstracts. Microb. Ecol. Health Dis. 5 (1992) I–XI.

  20. Malchow, H. Colonisation of adults with an apathogenicEscherichia coli strain after gut decontamination. Microb. Ecol. Health Dis 5 (1992) IX-X.

    Google Scholar 

  21. Bruckschen, E., Horosiewicz, H. Chronische Obstipation. Vergleich von mikrobiologischer Therapie und Lactulose. Münch. Med. Wochenschr. 16 (1994) 241–245.

    Google Scholar 

  22. Möllenbrink, M., Bruckschen, E. Behandlung der chronischen Obstipation mit physiologischenEscherichia-coli-Bakterien. Ergebnisse einer klinischen Studie zur Wirksamkeit und Verträglichkeit der mikrobiologischen Therapie mit demE. coli-Stamm Nissle 1917 (Mutaflor®) Med Klinik 89 (1994) 587–593.

    Google Scholar 

  23. Malchow, H.: E. coli strain Nissle 1917 — a new approach in adjuvant therapy of Crohn's disease (manuscript submitted).

  24. Kruis, W., Schütz, E., Stolte, M., Fixa, B., Fric, P., Judmaier, G.: Double-blind comparison between mesalazine and a preparation of viableE. coli Nissle 1917 for maintenance therapy of ulcerative colitis; accepted for presentation at the American Gastroenterology Association (AGA) Meeting in San Diego, May 1995.

  25. Lodinova-Zadnikova, R., Sonnenborn, U. (manuscript in preparation).

  26. Duval-Iflah, Y., Ouriet, M.-F., Moreau, C., Daniel, N., Gabilan, J.-C., Raibaud, P. Implantation précoce d'une souche deEscherichia coli dans l'intestine de nouveaunés humains: Effect de barrière vis-à-vis de souches deE. coli antibiorésistantes. Ann. Microbiol. (Inst. Pasteur) 133 A (1982) 393–408.

    Google Scholar 

  27. Poisson, D. M., Borderon, J. C., Amorim-Sena, J. C., Laugier, J. Evolution of the barrier effects against an exogenous drug-sensitiveEscherichia coli strain after single or repeated oral administration to newborns and infants aged up to three months admitted to an intensive-care unit. Biol. Neonate 49 (1986) 1–7.

    Google Scholar 

  28. Lari, A. R., Gold, F., Borderon, J. C., Laugier, J., Lafont, J-P. Implantation andin vivo antagonistic effects of antibiotic-susceptibleEscherichia coli strains administered to premature newborns. Biol. Neonate 58 (1990) 73–78.

    Google Scholar 

  29. Mertz, A. Behandlungsversuche bei ernährungsgestörten Säuglingen mit Mutaflor (Aufschwemmung von Kolibakterien mit hohem antagonistischen Index nach Nissle). Monatsschr. Kinderheilk. 18 (1920) 401–416.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. Clinical Research, Ardeypharm GmbH, Loerfeldstr. 20, D-58313, Herdecke, Germany

    J. Schulze

  2. Dept. Biological Research, Ardeypharm GmbH, Loerfeldstr. 20, D-58313, Herdecke, Germany

    U. Sonnenborn

Authors
  1. J. Schulze
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Sonnenborn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schulze, J., Sonnenborn, U. Re.: Oral administration of a certain strain of liveEscherichia coli for intestinal disorders? (Infection 23 [1995] 51–54). Infection 23, 184–186 (1995). https://doi.org/10.1007/BF01793863

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01793863

Keywords

Search

Navigation